Cutaneous Leishmaniasis Unknown Status Phase 3 Trials for Meglumine antimoniate (DB13732)

Also known as: Leishmaniasis, Cutaneous / Cutaneous leishmaniasis (disorder)

IndicationStatusPhase
DBCOND0028439 (Cutaneous Leishmaniasis)Unknown Status3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00487253Oral Miltefosine for the Treatment of Pediatric Cutaneous Leishmaniasis in ColombiaTreatment